138 related articles for article (PubMed ID: 38123939)
1. Delayed Gadolinium Leakage in Ocular Structures on Brain MR Imaging: Prevalence and Associated Factors.
Olatunji R; Lim TR; Jones B; Tafur M; Mathur S; Lin AW; Bharatha A; Suthiphosuwan S
AJNR Am J Neuroradiol; 2023 Dec; 45(1):90-95. PubMed ID: 38123939
[TBL] [Abstract][Full Text] [Related]
2. Delayed Gadolinium Leakage in Ocular Structures: A Potential Marker for Age- and Vascular Risk Factor-Related Small Vessel Disease?
Galmiche C; Moal B; Marnat G; Sagnier S; Schweitzer C; Dousset V; Sibon I; Tourdias T
Invest Radiol; 2021 Jul; 56(7):425-432. PubMed ID: 33481460
[TBL] [Abstract][Full Text] [Related]
3. Asymmetrical Gadolinium Leakage in Ocular Structures in Stroke Due to Internal Carotid Artery Stenosis or Occlusion.
Förster A; Wenz H; Böhme J; Groden C; Alonso A
Clin Neuroradiol; 2020 Jun; 30(2):221-228. PubMed ID: 30593604
[TBL] [Abstract][Full Text] [Related]
4. GLOS and HARM in patients with transient neurovascular symptoms with and without ischemic infarction.
Förster A; Ramos A; Wenz H; Böhme J; Groden C; Alonso A
J Neuroradiol; 2022 May; 49(3):244-249. PubMed ID: 33836217
[TBL] [Abstract][Full Text] [Related]
5. Blood-ocular barrier disruption in patients with acute stroke.
Hitomi E; Simpkins AN; Luby M; Latour LL; Leigh RJ; Leigh R
Neurology; 2018 Mar; 90(11):e915-e923. PubMed ID: 29438039
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium leakage in ocular structures: A novel MRI finding in transient global amnesia.
Förster A; Wenz H; Böhme J; Groden C
J Neurol Sci; 2019 Sep; 404():63-65. PubMed ID: 31330456
[TBL] [Abstract][Full Text] [Related]
7. Gadolinium leakage in ocular structures in optic neuritis.
Förster A; Böhme J; Groden C; Wenz H
J Clin Neurosci; 2019 Oct; 68():268-270. PubMed ID: 31204221
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium Leakage in Ocular Structures Is Common in Lacunar Infarction.
Förster A; Al-Zghloul M; Wenz H; Böhme J; Groden C; Alonso A
Stroke; 2019 Jan; 50(1):193-195. PubMed ID: 30580698
[TBL] [Abstract][Full Text] [Related]
9. Impact of Kidney Function on CNS Gadolinium Deposition in Patients Receiving Repeated Doses of Gadobutrol.
Dogra S; Borja MJ; Lui YW
AJNR Am J Neuroradiol; 2021 May; 42(5):824-830. PubMed ID: 33632738
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid changes after intravenous injection of gadolinium chelate: assessment by FLAIR MR imaging.
Bozzao A; Floris R; Fasoli F; Fantozzi LM; Colonnese C; Simonetti G
Eur Radiol; 2003 Mar; 13(3):592-7. PubMed ID: 12594563
[TBL] [Abstract][Full Text] [Related]
11. Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation.
Stanescu AL; Shaw DW; Murata N; Murata K; Rutledge JC; Maloney E; Maravilla KR
Pediatr Radiol; 2020 Mar; 50(3):388-396. PubMed ID: 31989188
[TBL] [Abstract][Full Text] [Related]
12. Hyperintense acute reperfusion marker is associated with higher contrast agent dosage in acute ischaemic stroke.
Ostwaldt AC; Rozanski M; Schaefer T; Ebinger M; Jungehülsing GJ; Villringer K; Fiebach JB
Eur Radiol; 2015 Nov; 25(11):3161-6. PubMed ID: 25899419
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium Deposition in Human Brain Tissues after Contrast-enhanced MR Imaging in Adult Patients without Intracranial Abnormalities.
McDonald RJ; McDonald JS; Kallmes DF; Jentoft ME; Paolini MA; Murray DL; Williamson EE; Eckel LJ
Radiology; 2017 Nov; 285(2):546-554. PubMed ID: 28653860
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW
AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583
[TBL] [Abstract][Full Text] [Related]
15. Peripheral Retinal Leakage after Intravenous Administration of a Gadolinium-based Contrast Agent: Age Dependence, Temporal and Inferior Predominance and Potential Implications for Eye Homeostasis.
Naganawa S; Ito R; Kawamura M; Taoka T; Yoshida T; Sone M
Magn Reson Med Sci; 2023 Jan; 22(1):45-55. PubMed ID: 34657903
[TBL] [Abstract][Full Text] [Related]
16. The anterior eye chamber: entry of the natural excretion pathway of gadolinium contrast agents?
Deike-Hofmann K; von Lampe P; Schlemmer HP; Bechrakis N; Kleinschnitz C; Forsting M; Radbruch A
Eur Radiol; 2020 Aug; 30(8):4633-4640. PubMed ID: 32179994
[TBL] [Abstract][Full Text] [Related]
17. Glymphatic Pathway of Gadolinium-Based Contrast Agents Through the Brain: Overlooked and Misinterpreted.
Deike-Hofmann K; Reuter J; Haase R; Paech D; Gnirs R; Bickelhaupt S; Forsting M; Heußel CP; Schlemmer HP; Radbruch A
Invest Radiol; 2019 Apr; 54(4):229-237. PubMed ID: 30480554
[TBL] [Abstract][Full Text] [Related]
18. High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.
Ramalho J; Castillo M; AlObaidy M; Nunes RH; Ramalho M; Dale BM; Semelka RC
Radiology; 2015 Sep; 276(3):836-44. PubMed ID: 26079490
[TBL] [Abstract][Full Text] [Related]
19. Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines.
Wang Y; Alkasab TK; Narin O; Nazarian RM; Kaewlai R; Kay J; Abujudeh HH
Radiology; 2011 Jul; 260(1):105-11. PubMed ID: 21586680
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
